This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Most common premalignant skin condition.
  • Dysplastic proliferations of keratinocytes with a potential for malignant transformation (1).
  • Characterized by multifocal scaly, hyperpigmented or scaly lesions, usually brown with a scaly base.
  • Histologically they are characterised by marked thickening of the keratin layer (hyperkeratosis) and the prickle cell layer (acanthosis). There may be a variable degree of dysplastic change and abnormal mitotic activity. However the basal layer remains intact.

Note 1 - there is debate whether actinic keratoses are premalignant conditions or alternatively early-stage squamous cell carcinoma (SCC). In a study of 459 patients with cutaneous SCC, there were associated adjacent actinic keratoses in 97% of the cases of cutaneous SCC (2).

Note 2 - there has been tremendous variation in the reported risk of progression of actinic keratosis to invasive SCC (between 0.025% to 16% per year). There is currently no existing technology to distinguish between actinic keratosis lesions that will clear, remain stable, or progress to invasive disease. (3)

Click here for example images of this condition


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.